Trial Profile
A Phase 1, Four-part, Fixed-sequence, Open-label Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs BMS 986360 (Primary) ; Digoxin; Metformin; Midazolam; Nintedanib; Omeprazole; Rosuvastatin; Warfarin
- Indications Idiopathic pulmonary fibrosis
- Focus Pharmacodynamics
- Sponsors Celgene Corporation
- 24 Jan 2019 Status changed from not yet recruiting to completed.
- 08 Dec 2017 New trial record